Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GATE-102
- Development stage
- Unknown
- Lead developer
- Syndeio Biosciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
GATE-102 is an orally bioavailable small molecule that acts as a positive allosteric modulator (PAM) of the N-methyl-D-aspartate (NMDA) receptor. Originally developed by Allergan (later AbbVie) as AGN-241751 and subsequently acquired by Gate Neurosciences, the compound is designed to enhance synaptic plasticity and restore dendritic spine density, which are often diminished in patients with neuropsychiatric conditions. Unlike NMDA antagonists such as ketamine, GATE-102's mechanism as a PAM aims to provide rapid and sustained antidepressant effects with an improved safety profile, specifically avoiding the dissociative and sedative side effects associated with receptor blockade. It is currently being developed for the treatment of major depressive disorder (MDD).
- Other names
- AGN 241751AGN241751AGN-241751
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on GATE-102.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GATE-102.